Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

A critical factor for eliminating disparities and ensuring health equity is the guarantee that all people have access to quality, affordable health care.

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

Our latest survey finds that protecting no-cost screenings and preventive care and reducing the burden of medical debt are the most impotant priorities for cancer patients and survivors. This survey also explores the impacts of cancer on food and nutrition insecurity, with impacts felt across income groups and coverage levels.

The American Cancer Society Cancer Action Network (ACS CAN) believes everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of income, race, gender identity, sexual orientation, disability status, or where they live. From preventive screening and early detection, through diagnosis and treatment, and into survivorship, there are several factors that influence cancer disparities among different populations across the cancer continuum.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

Current federal law provides life-saving coverage of cancer prevention and early detection services and programs.  These provisions are crucial to reducing the incidence and impact of cancer in the United States.  They are also crucial in helping cancer survivors remain cancer-free and lead healthy lives.

  •  

Tobacco Control Resources:

In 1999, the U.S. Department of Justice (DOJ) filed a lawsuit against major tobacco manufacturers Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria to hold the industry accountable for more than 50 years of conspiring to defraud the public in violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. Big Tobacco, an industry which has for decades knowingly addicted and endangered the lives of millions of Americans for their own profit, must now post the truth about their deadly products, including at the point-of-sale (POS) for approximately 220,000 tobacco retailers.

The tobacco industry has a history of using litigation to avoid and delay laws and regulations enacted to safeguard the public. ACS CAN, with our tobacco control partners, has also relied on the courts to hold Big Tobacco accountable and to ensure the federal government is effectively implementing the Tobacco Control Act.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

  •  

Screening Resources:

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to fund the Centers for Disease Control and Prevention’s (CDC) lifesaving Colorectal Cancer Control Program (CRCCP) at $51 million in FY 2027.

Our latest survey finds that cancer patients and survivors living in rural communities are significantly more likely than those in other areas to find it difficult to afford their health care and to accumulate medical debt related to their cancer care. As a result of these additional cost burdens, rural cancer patients and survivors are more likely to skip or delay recommended medical care, skip or delay taking a prescribed medication, fall behind on recommended cancer screenings, and to face food insecurity.

Overall, colorectal cancer incidence has declined largely attributed to an increase in screening and changes in risk factors. However, this trend is not consistent across all age groups.

After declining through much of the late 2000s and early 2010s, prostate cancer incidence rates have risen for nearly a decade. The increase includes distant-stage disease diagnoses among men of all ages, climbing by nearly 3% annually among those younger than 55 years.

El cáncer de seno es el tipo de cáncer que se diagnostica con mayor frecuencia en mujeres en EE.UU. Aunque en lasúltimas décadas se han logrado avances sustanciales en la reducción de la mortalidad por esta enfermedad,persisten desigualdades, especialmente entre las mujeres de raza negra.

Breast cancer screening is a continuum. It begins with a screening mammogram, which is often free for most insured women.

ACS CAN supports the Access to Breast Cancer Diagnosis Act to increase access to no cost breast cancer screening, including all diagnostic and supplemental tests.

Our latest survey finds that 31% of screening-age adults have been more than one year behind on recommended routine cancer screenings. Over half say out-of-pocket costs are a barrier to getting screened, while 47% report that getting insurance approvals for covered screenings is a barrier.